Oxidative stress and mitochondrial dysfunction in neurodegeneration of transmissible spongiform encephalopathies (TSEs)

Neurodegeneration and Prion Disease

Volumn , Issue , 2005, Pages 195-216

  Kim, Boe Hyun ^a   Kim, Jae II ^b   Carp, Richard I ^b   Kim, Yong Sun ^a  

^a Department of Psychology Hellym University   (South Korea)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900089383     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-23923-5_8     Document Type: Chapter

References (117)

1. S. Melove, Mitochondrial oxidative stress: physiologic consequences and potential for a role in aging, Ann. N. Y. Acad. Sci. 908, 219-225 (2000).
2. S. Melove, P. Coskun, M. Patel, R. Tuinistra, B. Cottrell, A. S. Jun, T. H. Zastawny, M. Dizdaroglu, S. I. Goodman, T. Huang, H. Miziorko, C. J. Epstein, D. C. Wallace, Mitochondrial disease in superoxide dismutase 2 mutant mice, Proc. Natl. Acad. Sci. USA. 96, 846-851 (1999).
3. M. F. Beal, N. Howell, I. Bodis Wallner, eds., Mitochondria and free radicals in neurodegenerative diseases. New York, N. Y., Wiley-Liss (1997).
4. D. R. Green, J. C. Reed, Mitochondria and apoptosis, Science 281, 1309-1312 (1998)
5. D. G. Nicholls, S. L. Budd, Mitochondria and neuronal survival, Physiol. Rev. 80, 315-360 (2000).
6. T. Kuwana, J. J. Smith, M. Muzio, V. Dixit, D. D. Newmeyer, S. Kornbluth, Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c, J. Biol. Chem. 273, 16589-16594 (1998).
7. S. A. Susin, H. K. Lorenzo, N. I. Zamzami, A. Marzo, B. E. Snow, G. M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D. R. Goodlett, R. Aebersold, D. P. Siderovski, J. M. Penninger, G. Kroemer, Molecular characterization of mitochondiral apoptosis-inducing factor, Nature 397, 441-446 (1999).
8. V. E. Kagan, E. Serbinova, L. Packer, Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling, Biochem. Biophys. Res. Commun. 169, 851-857 (1990).
9. V. E. Kagan, A. Shvedova, E. Serbinova, S. Khan, C. Swanson, R. Powell, L. Packer, Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase: reduction of peroxyl, ascorbyl and chromanoxyl radicals, Biochem. Pharmacol. 44, 1637-1649 (1992).
10. V. E. Kagan, Y. Y. Tyurina, Recycling and redox cycling of phenolic antioxidant, Ann. N. Y. Acad. Sci. 854, 425-434 (1998).
11. J. J. Maguire, V. Kagan, B. A. C. Ackrell, E. Serbinova, L. Packer, Succinateubiquinone reductase linked recycling of α-tocopherol in reconstituted systems and mitochondria: requirement for reduced ubiquinone, Arch. Biochem. Biophys. 292, 47-53 (1992).
12. D. A. Stoyanovsky, A. N. Osipov, P. J. Quinn, V. E. Kagan, Ubiquinone-dependent recycling of vitamin E radicals by superoxide, Arch. Biochem. Biophys. 323, 343-351 (1995).
13. M. Hiramatsu, R. D. Velasco, D. S. Wilson, L. Packer, Ubiquinone protects against loss of tocopherol in rat liver microsomes and mitochondrial membranes, Res. Commun. Chem. Phaol. Pharmacol. 72, 231-241 (1991).
14. A. C. Rego, C. R. Oliveira, Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases, Neurochem. Res. 28, 1563-1574 (2003).
15. J. G. McCormack, A. P. Halestrap, R. M. Denton, Role of calcium ions in regulation of mammalian intramitochondrial metabolism, Physiol. Rev. 70, 391-425 (1990).
16. T. E. Gunter, K. K. Gunter, S. S. Sheu, C. E. Gavin, Mitochondrial calcium transport: physiological and pathological evidence, Am. J. Physiol. 267, C313-C339 (1994).
17. 2+ transients, Biochim. Biophys. Acta. 1366, 5-15 (1998).
18. G. Hajnóczky, L. D. Robb-Gaspers, M. B. Seitz, A. P. Thomas, Decoding the cytosolic calcium oscillations in the mitochondria, Cell 82, 415-424 (1995).
19. 2+ revealed by specifically targeted recombinant aequorin, Nature 358, 325-327 (1992).
20. L. D. Robb-Gaspers, G. A. Rutter, P. G. Burnett, P. Hajnóczky, R. M. Denton, A. P. Thomas, Coupling between cytosolic and mitochondrial calcium oscillations: role in the regulation of hepatic metabolism, Biochim. Biophys. Acta. 1366, 17-22 (1998).
21. J. V. Leonard, A. H. Schapira, Mitochondrial respiratory chain disorders, I: mitochondrial DNA defects, Lancet 355, 299-304 (2000).
22. A. H. Schapira, Mitochondrial disorders, Biochim. Biophys. Acta. 1410, 99-102 (1999).
23. M. Hirano, M. Davidson, S. DiMauro, Mitochondria and the heart, Curr. Opin. Cardiol. 16, 201-210 (2001).
24. H. H. M. Dahl, Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome, Am. J. Hum. Genet. 63, 1594-1597 (1998).
25. M. B. Delatycki, R. Williamson, S. M. Forrest, Freidreich ataxia: an overview, J. Med. Genet. 37, 1-8 (2000).
26. R. G. Allen, M. Tresini, Oxidative stress and gene regulation, Free. Radic. Biol. Med. 28, 463-499 (2000).
27. A. Frandsen, A. Schousboe, Excitoatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons, J. Neurochem. 60, 1202-1211 (1993).
28. B. J. Tabner, S. Turnbull, O. M. A. El-Agnaf, D. Allsop, Production of reactive oxygen species from aggregating proteins implicated in Alzheimer'a disease, Parkinson's disease and other neurodegenerative diseases, Curr. Top. Med. Chem. 1, 507-517 (2001).
29. D. A. Harris, Cellular biology of prion diseases, Clin. Microbiol. Rev. 12, 429-444 (1999).
30. C. N. O'Donovan, D. Tobin, T. G. Cotterm, Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells, J. Biol. Chem. 276, 43516-43523 (2001).
31. S. B. Prusiner, Prions, Proc. Natl. Acad. Sci. USA 95, 13363-13383 (1998).
32. M. R. Scott, S. Supattapone, H. O. Nguyen, S. J. DeArmond, S. B. Prusiner, Transgenic models of prion disease, Arch. Virol. Suppl. 16, 113-124 (2000).
33. C. Weissmann, E. Flechsig, PrP knock-out and PrP transgenic mice in prion research, Br. Med. Bull. 66, 43-60 (2003).
34. T. Pillot, L. Lins, M. Goethals, B. Vanloo, J. Baert, J. Vandekerckhove, M. Rosseneu, R. Brasseur, The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion, J. Mol. Biol. 274, 381-393 (1997).
35. M. Pérez, F. Wandosell, C. Colaco, J. Avila, Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment, Biochem. J. 335, 369-374 (1998).
36. G. Forloni, N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani, F. Taliavinim, Neurotoxicity of a prion protein fragment, Nature 362, 543-546 (1993).
37. X. Huang, C. S. Atwood, M. A. Hartshorn, G. Multhaup, L. E. Goldstein, R. C. Scarpa, M. P. Caujungco, D. N. Gray, J. Lim, R. D. Moir, R. E. Tanzi, A. I. Bush, The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal iron reduction, Biochemistry 38, 7609-7616 (1999).
38. K. Hensley, J. M. Carney, M. P. Mattson, M. Aksenova, M. Harris, J. F. Wu, R. A. Floyd, D. A. Butterfield, A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease, Proc. Natl. Acad. Sci. USA 91, 3270-3274 (1994).
39. P. Agostinho, C. R. Oliveira, Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides, Eur, J. Neurosci. 17, 1189-1196 (2003).
40. C) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation, Brain Res. Mol. Brain Res. 124, 40-50 (2004).
41. S. I. Choi, W. K. Ju, E. K. Choi, J. Kim, H. Z. Lea, R. I. Carp, H. M. Wisniewski, Y. S. Kim, Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263K scrapie agent, Acta Neuropathol. (Berl.) 96, 279-286 (1998).
42. D. R. Brown, R. St. J. Nicholas, L. Canevari, Lack of prion protein expression results in a neuronal phenotype sensitive to stress, J. Neurosci. Res. 67, 211-224 (2002).
43. J. I. Kim, W. K. Ju, J. H. Choi, J. Kim, E. K. Choi, R. I. Carp, H. M. Wisniewski, Y. S. Kim, Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice, Brain Res. Mol. Brain. Res. 73, 17-27 (1999).
44. 2+-induced mitochondrial membrane permeabilization: Role of coenzyme Q redox state, Am. J. Physiol. 269, 141-147 (1995).
45. J. W. Herms, S. Korte, S. Gall, I. Schneider, S. Dunker, H. A. Kretzschmar, Altered intracellular calcium homeostasis in cerebellar granule cells of prion protein-deficient mice, J. Neurochem. 75, 1487-1492 (2000).
46. M. Kuwahara, Y. Kuroda, N. Arispe, E. Rojas, Alzheimer's β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line, J. Biol. Chem. 275, 14077-14083 (2000).
47. T. Forio, S. Thellung, C. Amico, M. Robello, M. Salmona, Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line, J. Neurosci. Res. 54, 341-352 (1998).
48. S. Thellung, T. Florio, V. Villa, A. Corsaro, S. Arena, F. Tagliavini, G. Schettini, Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126, Neurobiol. Dis. 7, 299-309 (2000).
49. V. Silei, C. Fabrizi, G. Venturini, M. Salmona, O. Bugiani, F. Taliavini, G. M. Lauro, Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels, Brain Res. 818, 168-170 (1999).
50. P. D. Guta, K. Pushkala, Importance of the role of calcium in programmed cell death: a review, Cytobios. 99, 83-95 (1999).
51. D. R. Brown, J. W. Herms, B. Schmidt, H. A. Kretzschmar, PrP and β-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells, Eur. J. Neurosci. 9, 1162-1169 (1997).
52. L. Zhang, J. Chen, I. I. Fu, Suppression of apoptosis signal regulating kinase I-induced cell death by 14-3-3 proteins, Proc. Natl. Acad. Sci. USA 96, 8511-8515 (1999).
53. J. Springer, R. D. Azbill, S. A. Nottingham, S. E. Kennedy, Clacineurin-mediated BAD dephosphorylation activated the caspase-3 apoptotic cascade in traumatic spinal cord injury, J. Neurosci. 20, 7246-7251 (2000).
54. S. Desagher, J. C. Martinou, Mitochondria as the central control point of apoptosis, Trends. Cell. Biol. 10, 369-377 (2000).
55. J. J. Lemasters, T. Qian, S. P. Elmore, L. C. Brenner, A. L. Nieminen, Confocal microscopy of the mitochondrial permeability transition in necrotic cell killing, apoptosis and autophagy, Biofactors 8, 283-285 (1998).
56. J. G. Pastorino, M. Tafani, R. J. Rothman, A. Marcineviniute, J. B. Hoek, J. L. Farboer, Functional consequences of the sustained or transition pore, J. Biol. Chem. 274, 31734-31739 (1999).
57. 2+ ions, J. Cell. Biol. 143, 217-224 (1998).
58. S. K. Park, S. I. Choi, J. K. Jin, E. K. Choi, J. I. Kim, R. I. Carp, Y. S. Kim, Differential expression of Bax and Bcl-2 in the brains of hamsters infected with 263K scrapie agent, Neuroreport 11, 1677-1682 (2000).
59. J. K. Jin, J. K. Choi, H. G. Lee, Y. S. Kim, R. I. Carp, E. K. Choi, Increased expression of CaM kinase II alpha in the brains of scrapie-infected mice, Neurosci. Lett. 273, 37-40 (1999).
60. A. Atlante, P. Calissano, A. Bobba, A. Azzariti, E. Marra, S. Passarella, Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing exitotoxic death, J. Biol. Chem. 275, 37159-37166 (2000).
61. H. G. Lee, S. I. Choi, S. K. Park, N. H. Kim, E. K. Choi, R. I. Carp, Y. S. Kim, Alternation of glutathoine metabolism and abnormal calcium accumulation in the mitochondria of hamster brain infected with scrapie agent, Neurobiol. Aging 21, S151 (2000).
62. Y. G. Choi, J. I. Kim, H. P. Lee, J. K. Jin, E. K. Choi, R. I. Carp, Y. S. Kim, Induction of heme oxygenase-1 in the brains of scrapie-infected mice, Neurosci. Lett. 289, 173-176 (2000).
63. N. H. Kim, S. J. Park, J. K. Jin, M. S. Kwon, E. K. Choi, R. I. Carp, Y. S. Kim, Increased ferric iron content and iron-induced oxidative stress in the brains of scrpie-infected mice, Brain Res. 884, 98-103 (2000).
64. D. R. Brown, K. F. Qin, J. W. Herms, A. Madlung, J. Manson, R. Strome, P. E. Frase, T. Kruck, A. Bonbohlen, W. Schulzschaeffer, A. Giese, D. Westaway, H. Kretzschmar, The cellular prion protein binds copper in vivo, Nature 390, 684-687 (1997).
65. R. G. Allen, Oxidative stress and supeoxide dismutase in development, aging and gene regulation, Age 21, 47-76 (1998).
66. M. Karin, T. Hunter, Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus, Curr. Biol. 5, 747-757 (1995).
67. A. Baba, E. Lee, T. Matsuda, T. Kihara, H. Iwata, Reversible inhibition of adenylate cyclase activity of rat brain caudate nucleus by oxidized glutathione. Biochim. Biophys. Acta. 85, 1204-1210 (1978).
68. T. G. Boulton, S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. H. Cobb, G. D. Yancopoulos, ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, Cell 65, 663-675 (1991).
69. ERK1, Mol. Cell. Biol. 13, 4679-4690 (1993).
70. C. Lechner, M. A. Zahalka, J. F. Giot, N. P. Moller, A. Ullrich, ERK6, a mitogenactivated protein kinase involved in C2C12 myoblast differentiation, Proc. Nat l. Acad. Sci. USA 93, 4355-4359 (1996).
71. MAPK, a novel human homolog of rat ERK-3, Mol. Cell, Biol. 14, 8202-8211 (1994).
72. R. Carletti, S. Tacconi, E. Bettini, F. Ferraguti, Stress activated protein kinases, a novel family of mitogen-activated protein kinases, are heterogeneously expressed in the adult rat brain and differentially distributed from extracellular-signal-regulated protein kinases, Neuroscience 69, 1103-1110 (1995).
73. R. J. Davis, MAPKs: new JNK expands the group, Trends Biochem. Sci. 19, 470-473 (1994).
74. J. M. Kyriakis, P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, J. R. Woodgett, The stress-activated protein kinase subfamily of c-jun kinases, Nature 369, 156-160 (1994).
75. S. Mertens, M. Craxton, M. Goedert, SAP kinase-3, a new member of the family mammalian stress-activated protein kinases, FEBS Lett. 383, 273-276 (1996).
76. J. R. Woodgett, J. Avruch, J. Kyriakis, The stress activated protein kinase pathway, Cancer Surv. 27, 127-138 (1996).
77. Y Jiang, C. Chen, Z. Li, W. Guo, J. A. Gegner, S. Lin, J. Han, Characterization of the structure and function of a new mitogen-activated protein kinase (p38β), J. Biol. Chem. 271, 17920-17926 (1996).
78. Y Jiang, H. Gram, M. Zhao, L. New, J. Gu, L. Feng, F. Di Padova, R. J. Ulevitch, J. Han, Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ, J. Biol. Chem. 272, 30122-30128 (1997).
79. Z. Li, Y Jiang, R. J. Ulevitch, J. Han, The primary structure of p38γ: a new member of p38 group of MAP kinases, Biochem. Biophys. Res. Commun. 228, 334-340 (1996).
80. B. Stein, M. X. Yang, D. B. Young, R. Janknecht, T. Hunter, B. W. Murray, M. S. Barbosa, p38-2, a novel mitogen-activated protein kinase with distinct properties, J. Biol. Chem. 272, 19509-19517 (1997).
81. J. D. Lee, R. J. Ulevitch, J. Han, Primary structure of BMK1: a new mammalian map kinase, Biochem. Biophys. Res. Commun. 213, 715-724 (1995).
82. G. Zhou, Z. Q. Bao, J. E. Dixon, Components of a new human protein kinase signal transduction pathway, J. Biol. Chem. 270, 12665-12669 (1995).
83. P. Chardin, J. H. Camonis, N. W. Gale, L. van Aelst, J. Schlessinger, M. H. Wigler, D. Bar-Sagi, Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2, Science 260, 1338-1343 (1993).
84. R. J. Grand, D. Owen, The biochemistry of ras p21, Biochem. J. 279, 609-631 (1991).
85. I. G. Macara, K. M. Lounsbury, S. A. Richards, C. McKiernan, D. Bar-Sagi, The Ras superfamily of GTPases, FASEB J. 10, 625-630 (1996).
86. S. J. Taylor, D. Shalloway, Cell cycle-dependent activation of Ras, Curr. Biol. 6, 1621-1627 (1996).
87. K. Irani, Y. Xia, J. L. Zweier, S. J. Sollott, C. J. Der, E. R. Fearson, M. Sundaresan, T. Finkel, P. J. Goldschmidt-Clemont, Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts, Science 275, 1649-1652 (1997).
88. F. Zhang, A. Strand, D. Robbins, M. H. Cobb, E. J. Goldsmith, Atomic structure of the MAP kinase ERK2 at 2.3 A resolution, Nature 367, 704-711 (1994).
89. R. Janknecht, W. H. Ernst, V. Pingoud, A. Nordheim, Activation of ternary complex factor Elk-1 by MAP kinase, EMBO J. 12, 5097-5104 (1993).
90. R. Janknecht, W. H. Ernst, A. Nordheim, SAP1a is a nuclear target of signaling cascades involving ERKs, Oncogene 10, 1209-1216 (1995).
91. A. J. Whitmarsh, P. Shore, A. D. Sharrocks, R. J. Davis, Integration of MAP kinase signal transduction pathways at the serum responsive element, Science 269, 403-407 (1995).
92. R. Janknecht, T. Hunter, Convergence of MAP kinase pathways on the ternary complex factor Sap-1α, EMBO J. 16, 1620-1627 (1997).
93. M. A. Price, C. Hill, R. Treisman, Integration of growth factor signals at the c-fos serum response element, Philos. Trans. R. Soc. Lond. B. Biol. Sci. 351, 551-559 (1996).
94. H. P. Lee, Y. C. Jeon, J. K. Choi, J. I. Kim, R. I. Carp, Y. S. Kim, The expression of RANTES and chemokine receptors in the brains of scrapie-infected mice, J. Neuroimmunol 158, 26-33 (2005).
95. Y. S. Kim, H. P. Lee, Y. C. Jun, J. K. Choi, J. I. Kim, R. I. Carp, Activation of mitogenactivated protein kinases (MAPKS) in hamster brains infected with 263K scrapie agent, Neurobiol. Aging Abstr. 25, S457 (2004).
96. B. Schneider, V. Mutel, M. Pietri, M. Ermonval, S. Mouillet-Richard, O. Kellermann, NADPH oxidase and extracelular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells, Proc. Natl. Acad. Sci. USA 100, 13326-13331 (2003).
97. S. Thellung, V. Villa, A. Corsaro, S. Arena, E. Millo, G. Damonte, U. Benatti, F. Tagliavini, T. Florio, G. Schettini, p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells, Neurobiol. Dis. 9, 69-81 (2002).
98. F. B. Hafiz, D. R. Brown, A model for the mechanism of astrogliosis in prion disease, Mol. Cell. Neurosci. 16, 221-232 (2000).
99. B. Meyrick, M. A. Magnusin, Identification and functional characterization of the bovine manganous superoxide dismutase gene, Am. J. Respir. Cell Mol. Biol. 10, 113-121 (1994).
100. X. S. Wan, M. N. Devalaraja, D. K. St. Clair, Molecular structure and organization of the human manganese superoxide dismutase gene, DNA Cell Biol. 13, 1127-1136 (1994).
101. A. A. Beg, S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, A. S. Baldwin Jr., IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention, Genes Dev. 6, 1899-1913 (1992).
102. R. Schreck, P. Rieber, P. A. Baeuerle, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1, EMBO J. 10, 2247-2258 (1991).
103. J. I. Kim, J. K. Jin, E. K. Choi, S. I. Choi, R. I. Carp, Y. S. Kim, Overexpression of cyclooxygenase-2 in astrocytes of scrapie-infected mice, Neurobiol. Aging 21, S87 (2000).
104. W. K. Ju, K. J. Park, E. K. Choi, J. Kim, R. I. Carp, H. M. Wisniewski, Y. S. Kim, Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice, J. Neurovirol. 4, 445-450 (1998).
105. Y. S. Kim, K. Hur, Y. C. Jun, E. A. Leibold, J. R. Connor, R. I. Carp, Altered expression of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapieinfected mice, 2002 Abstrac Viewer/Itinerary Planner. Washington, DC: Soc. Neurosci. Program No. 692.12(2002), Online.
106. K. Hur, J. I. Kim, S. I. Choi, E. K. Choi, R. I. Carp, Y. S. Kim, The pathogenic mechanisms of prion diseases, Mech. Ageing. Dev. 123, 1637-1647 (2002).
107. G. Rotilio, L. Rossi, A. De Martino, A. M. Da Costa Ferreira, M. R. Ciriolo, Free radical, metal ions and oxidative stress: Chemical mechanisms of damage and protection in living systems, J. Braz. Chem. Soc. 6, 221-227 (1995).
108. L. Rossi, M. F. Lombardo, M. R. Cirriolo, G. Rotilio, Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance, Neurochem. Res. 29, 493-504 (2004).
109. M. Glerum, A. Shtanko, A. Tzagoloff, Characterization of Cox17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase, J. Biol. Chem. 271, 14504-14509 (1996).
110. J. Klein, V. Chalifa, M. Liscovitch, K. Loffelholz, Role of phospholipase D activation in nervous system physiologyand pathophysiology, J. Neurochem. 65, 1445-1455 (1995).
111. J. K. Jin, N. H. Kim, D. S. Min, J. I. Kim, B. H. Jeong, S. I. Choi, E. K. Choi, R. I. Carp, Y. S. Kim, Increased expression of phospholipase D1 in the brains of scrapie-infected mice, J. Neurochem, [in press] (2005).
112. S. D. Yan, X. Chen, A. M. Schmidt, J. Brett, G. Godman, Y. S. Zou, C. W. Scott, C. Caputo, T. Frappier, M. A. Smith, G. Perry, S. H. Yen, D. Stern, Glycated Tau protein in Alzheimer disease: A mechanism for induction of oxidant stress, Proc. Natl. Acad. Sci. USA 91, 7787-7791 (1994).
113. M. Brownlee, A. Cerami, and H. Vlassara, Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N. Engl. J. Med. 318, 1315-1321 (1988).
114. R. Castellani, M. A. Smith, G. L. Richey and G. Perry, Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease, Brain Res. 737, 195-200 (1996).
115. Y. G. Choi, J. I. Kim, Y. C. Jeon, S. J. Park, E. K. Choi, R. Rubenstein, R. J. Kascsak, R. I. Carp, Y. S. Kim, Nonenzymatic glycation at the N-terminus of pathogenic prion protein in transmissible spongiform encephalopathies, J. Biol. Chem. 279, 30402-30409 (2004).
116. M. A. Smith, S. Taneda, P. L. Richey, S. Miyata, S. Yan, D. Stern, L. M. Sayre, V. M. Monnier, and G. Perry, Advanced Maillard Reaction End Products are Associated with Alzheimer Disease Pathology, Proc. Natl. Acad. Sci. USA 91, 5710-5714 (1994).
117. B. Halliwell, Reactive oxygen species and the central nervous system, J. Neurochem. 59, 1609-1623 (1992).